Abveris and Abilita Bio Announce a Discovery Collaboration to Develop Therapeutics for Challenging Membrane Protein Targets
- Tuesday, August 24, 2021, 7:35
- Business
- Add a comment
SAN DIEGO and CANTON, Mass., Aug. 24, 2021 /PRNewswire/ — Abveris, Inc. (“Abveris”) and Abilita Bio, Inc. (“Abilita”), both privately held biotechnology companies, announce a joint research collaboration that will leverage the synergies between their platforms to enable the discovery of…
About the Author
adminasapcorp has written 41850 stories on this site.